Influence of the stem design on the postoperative outcome in hip arthroplasty utilizing the minimally invasive anterior and anterolateral approach

Influence of the stem design on the postoperative outcome in hip arthroplasty utilizing the minimally invasive anterior and anterolateral approach - Stem design-MSM

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00033146

Enrollment

234

Registered

2023-11-29

Start date

2023-11-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16.1

Interventions

Group 1: AMIS, short stem Group 2: AMIS, straight stem Group 3: Minimally invasive anterolateral approach, supine position, short stem Group 4: Minimally invasive nterolateral approach, supine positio

Eligibility

Sex/Gender

All

Age

35 Years to 80 Years

Inclusion criteria

Inclusion criteria: BMI < 35, primary osteoarthritis of the hip

Exclusion criteria

Exclusion criteria: ASA4, tumour rheumatoid arthritis, severe contralateral hip arthritis, severe gonarthritis, radiculopathy, severe osteoporosis, implants not suitable for MRI, claustrophobia

Design outcomes

Primary

Measure	Time frame
Degree of muscle damage as quantified by MRI prior to surgery, 3 days and 6 months after surgery. In addition, skelettal Troponin T will be quantified preoperatively, 6h, 24h and 48h after surgery.	—

Secondary

Measure	Time frame
Oxford Hip Score, Troponin T, EQ-5D-5L, Forgotten Joint Score, Pain. Clinical follow-ups with determination of the above mentioned scores will take place 6 weeks as well as 3, 6 and 12 months after surgery	—

Countries

Germany

Contacts

Public ContactGeorgi Wassilew

Klinik für Orthopädie und Orthopädische Chirurgie, Universitätsmedizin Greifswald

ortho@med.uni-greifswald.de+49 3834 7051

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026